WPP (NYSE:WPP) today announces the acquisition of Passport Brand Design, a leading brand design agency based in Southern California.
Idera Pharma Acquires Rare Disease Player, Names New CEO
Idera Pharmaceuticals Inc (NASDAQ: IDRA) acquired Aceragen Inc, a privately-held biotechnology company focused on rare, orphan pulmonary, and rheumatic diseases.